ArticleInternational journal of molecular sciences2024
Comment on Borșa et al. Developing New Diagnostic Tools Based on SERS Analysis of Filtered Salivary Samples for Oral Cancer Detection.
Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
This comment discusses a recent research paper on the classification of saliva samples with SERS by Borsa et al. The authors suggested utilizing PCA-LDA to detect oral cancer and claimed to achieve an accuracy of up to 77%. Despite the high prediction capability of the proposed approach, the demonstrated findings could be treated as unclear due to possible overestimation of the proposed classification models. Data should be provided for both the training and the validation sets to make sure that there were no repeated data from the same sample in either set. Moreover, the authors proposed to measure opiorphin in saliva with SERS as a potential biomarker of oral cancer. However, opiorphin in saliva is contained in ng/mL concentrations, and the proposed technique is most likely not capable of recording the real concentration of opiorphin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.